Preferred Pharmaceuticals, Inc. is recalling 192 bottles of Robafen DM (a generic version of Robitussin DM) due to potential contamination with Burkholderia cepacia and Ralstonia pickettii bacteria. This recall includes 4 oz bottles of the cough and cold medication manufactured for Preferred Pharmaceuticals by Major Pharmaceuticals. Consumers should be aware that these bacteria can cause serious infections, particularly in individuals with weakened immune systems. If you have this product at home, you should immediately contact your healthcare provider or pharmacist for guidance.
The product may contain Burkholderia cepacia and Ralstonia pickettii, which are bacteria that can lead to life-threatening infections in people with cystic fibrosis or compromised immune systems. Healthy individuals might experience milder infections, but the presence of these pathogens in a liquid medication poses a significant health risk.
Healthcare consultation and pharmacy refund.
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.